How should this patient be managed? Pancreatic acinar cell carcinoma is a rare neoplasm that comprises about 1% of all exocrine pancreatic tumors. Clinically, it may present with nonspecific ...

pancreatic metaplasia and the so-called endocrine cell hyperplasia. Therefore, PDX-1 could be regarded as switch factor for endocrine and exocrine differentiation and transdifferentiation ...

Serum amylase and lipase are markers of pancreatic exocrine function, and the acinar (exocrine) pancreas typically manifests rejection prior to the endocrine pancreas. However, exocrine markers ...

What look like half-deflated soccer balls in the image above are 3-D re-creations of microscopic acini, clusters of cells in the pancreas that secrete digestive enzymes. Produced with computer ...

More than 80 out of 100 exocrine pancreatic cancers (more than 80%) are adenocarcinomas. Nearly all of these are ductal adenocarcinomas. They start in the cells lining the ducts of the pancreas.

and SNAP23 was known to participate in the endocrine function of pancreatic b cells and the exocrine function of acinar cells in the laboratory. However, the in vivo function of SNAP23 was unknown.

This type of pancreatic cancer begins in acinar cells, which are a type of exocrine cell. It accounts for only 1 –2% of pancreatic cancers and has no standard treatment. It is associated with ...